SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bacil Pharma - Quaterly Results

23 Oct 2024 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2024, as compared to corresponding quarter of last year.The Total Profit for the quarter ended September 2024 of Rs. 4.85 millions grew from Rs.-0.12 millions Operating profit Margin for the quarter ended September 2024 improved to 4.88% as compared to -0.11% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 5.60 0.29 1831.03 5.71 0.77 641.56 1.31 1.15 13.91
PBIDT 4.88 -0.11 -4536.36 4.55 0.07 6400.00 -0.57 -0.99 -42.42
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 4.88 -0.11 -4536.36 4.55 0.07 6400.00 -0.57 -0.99 -42.42
Depreciation 0.00 0.01 -100.00 0.00 0.02 -100.00 0.02 0.03 -33.33
PBT 4.88 -0.12 -4166.67 4.55 0.05 9000.00 -0.59 -1.02 -42.16
TAX 0.03 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.03 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00
PAT 4.85 -0.12 -4141.67 4.52 0.05 8940.00 -0.59 -1.02 -42.16
Equity 58.90 58.90 0.00 58.90 58.90 0.00 58.90 58.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bacil Pharma Share Price

52.27 -2.72 (-4.95%)
06-May-2026 10:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1832.40
Dr. Reddys Lab 1284.60
Cipla 1340.95
Zydus Lifesciences 926.95
Lupin 2391.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×